Williams detailed her decision in a Vogue interview published in August 2025, confirming her use of Zepbound and her desire to address stigma around GLP-1 drugs
doi: 10.1016/S0140-6736(09)61375-1 90 LeanMEJCarraroRFinerNHartvigHLindegaardMLRssnerSet al
GLP-1 medications do not directly cause vitamin deficiencies in everyone, but they can make them more likely over time by lowering appetite and reducing overall food intake
Over the next decade, several longer-acting versions were developed, including: Victoza (liraglutide) approved in 2010 Bydureon approved in 2012 Trulicity approved in 2014 During this period the medications were primarily prescribed for diabetes , and awareness outside medical circles was relatively limited
Fabi is also an assistant clinical professor at the University of California, San Diego
This approach has been validated through extensive clinical research